Therefore, the present study aims to explore first, whether different forms of ACE are associated with altered hsCRP levels, second, if specific forms of ACE are associated with the response to anti-depression treatment, third, whether the treatment response is also associated with hsCRP levels, and fourth, whether the hsCRP levels vary during anti-depressant treatment. This evidence concerns the gene ACE and depressive symptom measurement.